Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)

NCT02354222 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Canagliflozin
DRUG: Teneligliptin
DRUG: Placebo

Sponsor

Tanabe Pharma Corporation